Literature DB >> 18423555

How the new tools to analyze the human genome are opening new perspectives: the use of gene expression in investigations of the adrenal cortex.

C A Stratakis1, A Horvath.   

Abstract

With the promise of state-of-the-art molecular technologies and the tools provided by the human genome project, a number of investigators are trying to identify molecular targets of adrenocortical tumorigenesis. One path in this endeavor was the identification by positional cloning of genes that are mutated in rare adrenocortical tumors. The subject of this article is an update of the results of experiments in the second path that was followed by us and others: that of using genome-wide expression analysis of adrenocortical cells in normal and various disease states. Transcriptomic analysis is a rapidly evolving technology; this article summarizes some data on the adrenal cortex and points out how these new technologies can be used in the identification of important genes and molecular pathways in both normal and diseased adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18423555      PMCID: PMC2713065          DOI: 10.1016/j.ando.2008.02.009

Source DB:  PubMed          Journal:  Ann Endocrinol (Paris)        ISSN: 0003-4266            Impact factor:   2.478


  54 in total

1.  Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later.

Authors:  W F Young; J A Carney; B U Musa; N M Wulffraat; J W Lens; H A Drexhage
Journal:  N Engl J Med       Date:  1989-12-14       Impact factor: 91.245

2.  Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution.

Authors:  V K Han; P K Lund; D C Lee; A J D'Ercole
Journal:  J Clin Endocrinol Metab       Date:  1988-02       Impact factor: 5.958

3.  Cholesterol synthesis in human fetal tissues.

Authors:  B R Carr; E R Simpson
Journal:  J Clin Endocrinol Metab       Date:  1982-09       Impact factor: 5.958

4.  The effects of dexamethasone and anencephaly on newborn serum levels of apolipoprotein A-1.

Authors:  C R Parker; P C MacDonald; B R Carr; J C Morrison
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

5.  Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: an unusual cause of Cushing's syndrome.

Authors:  C D Malchoff; J Rosa; C R DeBold; R A Kozol; G R Ramsby; D L Page; D M Malchoff; D N Orth
Journal:  J Clin Endocrinol Metab       Date:  1989-04       Impact factor: 5.958

Review 6.  Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature.

Authors:  M Aiba; A Hirayama; H Iri; Y Ito; Y Fujimoto; G Mabuchi; M Murai; H Tazaki; H Maruyama; T Saruta
Journal:  Am J Clin Pathol       Date:  1991-09       Impact factor: 2.493

7.  Distinct transcriptional profiles of adrenocortical tumors uncovered by DNA microarray analysis.

Authors:  Thomas J Giordano; Dafydd G Thomas; Rork Kuick; Michelle Lizyness; David E Misek; Angela L Smith; Donita Sanders; Rima T Aljundi; Paul G Gauger; Norman W Thompson; Jeremy M G Taylor; Samir M Hanash
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

8.  Hypercholesterolemia due to elevated low density lipoprotein-cholesterol in newborns with anencephaly and adrenal atrophy.

Authors:  C R Parker; B R Carr; C A Winkel; M L Casey; E R Simpson; P C MacDonald
Journal:  J Clin Endocrinol Metab       Date:  1983-07       Impact factor: 5.958

Review 9.  Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony.

Authors:  Constantine A Stratakis
Journal:  Trends Endocrinol Metab       Date:  2003-11       Impact factor: 12.015

10.  FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern.

Authors:  J Partanen; T P Mäkelä; E Eerola; J Korhonen; H Hirvonen; L Claesson-Welsh; K Alitalo
Journal:  EMBO J       Date:  1991-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.